Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.38 is 207% above its 5-year average of -0.35, near the high end of its 5-year range (-1.33–0.38).
337.50% above its 12-month average of -0.16.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.42.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:26:49.024Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.38
EARNINGS PER SHARE (EPS) AVG TTM
-0.16
EARNINGS PER SHARE (EPS) AVG 3Y
-0.18
EARNINGS PER SHARE (EPS) AVG 5Y
-0.35
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+337.50%
CURRENT VS 3Y AVG
+312.14%
CURRENT VS 5Y AVG
+207.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eton Pharmaceuticals, Inc.
Market Cap
$1.51B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.53B
Earnings Per Share (EPS)
25.28
TTM Avg
10.68
3Y Avg
-22.38
5Y Avg
-5.21
Market Cap
$1.50B
Earnings Per Share (EPS)
2.44
TTM Avg
1.82
3Y Avg
1.13
5Y Avg
1.18
Market Cap
$1.54B
Earnings Per Share (EPS)
4.10
TTM Avg
2.19
3Y Avg
2.59
5Y Avg
2.64
Market Cap
$1.49B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.49B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
Market Cap
$1.47B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.05
3Y Avg
-2.66
5Y Avg
-2.66
Market Cap
$1.46B
Earnings Per Share (EPS)
1.71
TTM Avg
0.68
3Y Avg
0.58
5Y Avg
0.72
Market Cap
$1.48B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.51B | 0.38 | -0.16 | -0.18 | -0.35 |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 25.28 | 10.68 | -22.38 | -5.21 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 2.44 | 1.82 | 1.13 | 1.18 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 4.10 | 2.19 | 2.59 | 2.64 |
| Certara, Inc. (CERT)vs › | $1.49B | -0.44 | -0.04 | -0.09 | -0.12 |
| GH Research PLC (GHRS)vs › | $1.49B | -1.00 | -0.77 | -0.59 | -0.43 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | -2.74 | -3.05 | -2.66 | -2.66 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 1.71 | 0.68 | 0.58 | 0.72 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.58B | 0.84 | 0.16 | 0.00 | 0.42 |
Trailing EPS (TTM)
$0.38
Forward EPS (Est.)
$1.09
P/E Ratio
143.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.17 |
| 2024-12-31 | -0.15 |
| 2023-12-31 | -0.04 |
| 2022-12-31 | -0.36 |
| 2021-12-31 | -0.08 |
| 2020-12-31 | -1.33 |
| 2019-12-31 | -1.02 |
| 2018-12-31 | -1.99 |
| 2017-12-31 | -0.41 |
